GenSight Biologics announces publication of 5-year outcomes for patients treated unilaterally with Lumevoq gene therapy: Paris, France Thursday, January 16, 2025, 18:00 Hrs [IST] ...
Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback